AI assistant
HIKMA Pharmaceuticals PLC — Director's Dealing 2020
May 13, 2020
4841_dirs_2020-05-13_cdca1958-a645-4aae-b798-29507d2f52af.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
RNS Number : 8074M
Hikma Pharmaceuticals Plc
13 May 2020
Hikma Pharmaceuticals PLC
Notification and public disclosure of transactions by persons discharging managerial responsibilities
Said Darwazah
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |
| a) | Name | Said Darwazah |
| 2 | Reason for the notification | |
| a) | Position/status | Executive Chairman |
| b) | Initial notification /Amendment | Initial notification |
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
| a) | Name | Hikma Pharmaceuticals PLC |
| b) | LEI | 549300BNS685UXH4JI75 |
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
| a) | Description of the financial instrument, type of instrument and identification code | Description: Ordinary shares of 10 pence each ID Code: GB00B0LCW083 |
| b) | Nature of the transaction | Liquidation of HMS Holdings SAL resulting in the disposal of 1,350,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC. HMS Holdings SAL is defined as a Person Closely Associated with the Executive Chairman, who is a shareholder. |
| c) | Price(s) and volume(s) | Price(s): £24.50p Volume(s): 1,350,000 |
| d) | Aggregated information | Aggregated volume: 1,350,000 Price: £24.50p |
| e) | Date of the transaction | 13 May 2020 |
| f) | Place of the transaction | London |
Mazen Darwazah
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |
| a) | Name | Mazen Darwazah |
| 2 | Reason for the notification | |
| a) | Position/status | Executive Vice Chairman |
| b) | Initial notification /Amendment | Initial notification |
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
| a) | Name | Hikma Pharmaceuticals PLC |
| b) | LEI | 549300BNS685UXH4JI75 |
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
| a) | Description of the financial instrument, type of instrument and identification code | Description: Ordinary shares of 10 pence each ID Code: GB00B0LCW083 |
| b) | Nature of the transaction | Liquidation of HMS Holdings SAL resulting in the disposal of 1,350,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC. HMS Holdings SAL is defined as a Person Closely Associated with the Executive Vice Chairman, who is a shareholder. |
| c) | Price(s) and volume(s) | Price(s): £24.50p Volume(s): 1,350,000 |
| d) | Aggregated information | Aggregated volume: 1,350,000 Price: £24.50p |
| e) | Date of the transaction | 13 May 2020 |
| f) | Place of the transaction | London |
Peter Speirs
Company Secretary, responsible for releasing this announcement
+44 (0) 20 7399 2760
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
DSHBDGDULDBDGGX